Kim Yunje, Hwang Joungboon, Kim Myungsoo, Lee Won
Doping Control Center, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul, Korea.
Rapid Commun Mass Spectrom. 2003;17(4):301-6. doi: 10.1002/rcm.913.
Tripamide is a drug widely used in clinical practice for the treatment of hypertension and edema. This work evaluated a screening method for Tripamide and its urinary metabolites in human urine, using high-performance liquid chromatography diode-array detection (HPLC/DAD). Identification of these metabolites was investigated by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC/ESI-MS/MS) after dosing with 15 mg Tripamide. Acid hydrolysis showed that Tripamide is conjugated in the body. Two suspected metabolites were detected by HPLC/DAD. HPLC/ESI-MS/MS analysis suggested that these metabolites were probably hydroxylated together with loss of the -NH(2) group and dehydrogenation. These results will be useful in confirmation methods for Tripamide in doping control.
曲帕胺是一种在临床实践中广泛用于治疗高血压和水肿的药物。这项工作评估了一种使用高效液相色谱二极管阵列检测法(HPLC/DAD)检测人尿液中曲帕胺及其尿液代谢物的筛选方法。在给予15mg曲帕胺后,通过高效液相色谱/电喷雾电离串联质谱法(HPLC/ESI-MS/MS)研究了这些代谢物的鉴定。酸水解表明曲帕胺在体内发生了缀合。通过HPLC/DAD检测到两种疑似代谢物。HPLC/ESI-MS/MS分析表明,这些代谢物可能发生了羟基化,同时失去了 -NH(2) 基团并脱氢。这些结果将有助于在兴奋剂检测中确认曲帕胺的方法。